Published in Clin Rheumatol on December 01, 1987
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34
Stages of change and decisional balance for 12 problem behaviors. Health Psychol (1994) 9.28
Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis (1987) 9.25
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol (1997) 5.09
Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol (2000) 4.15
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage (2004) 4.01
The Epidemiology of low back pain. Best Pract Res Clin Rheumatol (2010) 3.96
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol (1998) 3.75
A clinician's guide for conducting randomized trials in individual patients. CMAJ (1988) 3.35
n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ (1994) 3.34
Homoeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial. Br J Clin Pharmacol (1980) 3.28
Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage (1996) 3.26
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
The preterm prediction study: maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol (1996) 3.09
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med (1990) 2.89
Repetitive strain injury. BMJ (1993) 2.81
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med (1993) 2.76
Refusing care to emergency department of patients: evaluation of published triage guidelines. Ann Emerg Med (1994) 2.76
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med (1990) 2.63
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost (2015) 2.46
Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43
Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthritis Cartilage (2000) 2.42
Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med (1967) 2.38
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage (2002) 2.14
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol (1999) 2.12
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum (2001) 2.11
Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol (1997) 2.11
Sleep and ventricular premature beats. Circulation (1973) 2.10
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
The use of botulinum toxin in the management of burns itching: preliminary results. Burns (2012) 2.04
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Hypothesis: that rheumatoid arthritis will disappear. J Rheumatol (1979) 2.01
Judging "current disease activity" in rheumatoid arthritis--an international comparison. J Rheumatol (1983) 2.01
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Responsiveness of the short form-36, disability of the arm, shoulder, and hand questionnaire, patient-rated wrist evaluation, and physical impairment measurements in evaluating recovery after a distal radius fracture. J Hand Surg Am (2000) 1.98
Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J (1973) 1.97
A systematic review of presumed consent systems for deceased organ donation. Health Technol Assess (2009) 1.96
Minimal clinically important differences: review of methods. J Rheumatol (2001) 1.94
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results. Osteoarthritis Cartilage (2002) 1.89
Hydroxymethyluracil DNA glycosylase in mammalian cells. Proc Natl Acad Sci U S A (1984) 1.83
A standardized protocol for measurement of range of movement of the shoulder using the Plurimeter-V inclinometer and assessment of its intrarater and interrater reliability. Arthritis Care Res (1998) 1.83
A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81
Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. N Engl J Med (1990) 1.80
Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q J Med (1973) 1.80
Speed enforcement detection devices for preventing road traffic injuries. Cochrane Database Syst Rev (2006) 1.77
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Gastric studies in sjögren's syndrome. Gut (1966) 1.73
A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee. Clin Rheumatol (1986) 1.70
Alcohol ignition interlock programmes for reducing drink driving recidivism. Cochrane Database Syst Rev (2004) 1.70
Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls. Clin Rheumatol (1989) 1.69
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69
Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease. Arch Intern Med (2000) 1.68
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
Observer variation in detecting the radiologic features associated with bronchiolitis. Invest Radiol (1991) 1.64
The articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation using radio-technetium. Clin Sci (1968) 1.60
Salicylates and homoeopathy in rheumatoid arthritis: preliminary observations. Br J Clin Pharmacol (1978) 1.59
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59
RSI--regional pain syndrome: the importance of nomenclature. Br J Rheumatol (1989) 1.58
The impact of re-engineering and other cost reduction strategies on the staff of a large teaching hospital: a longitudinal study. Med Care (1999) 1.57
Acute calcific tendinitis of the rectus femoris. J Bone Joint Surg Br (1996) 1.56
Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol Suppl (1994) 1.53
Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol (1992) 1.53
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52
Depression in rheumatoid arthritis. J R Coll Gen Pract (1977) 1.52
Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol (1979) 1.52
Clinical importance of pharmacist-obtained medication histories using a validated questionnaire. Am J Hosp Pharm (1984) 1.50
Pain following colonoscopy: elimination with carbon dioxide. Gastrointest Endosc (1992) 1.48
Comparison of the responsiveness and relative effect size of the western Ontario and McMaster Universities Osteoarthritis Index and the short-form Medical Outcomes Study Survey in a randomized, clinical trial of osteoarthritis patients. Arthritis Care Res (1999) 1.48
Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity. Ann Rheum Dis (1968) 1.47
Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol (2011) 1.46
Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol (1966) 1.43
Prior score availability: observations using the WOMAC osteoarthritis index. Br J Rheumatol (1991) 1.43
Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess (2009) 1.43
Preventive care and barriers to effective prevention. How do family physicians see it? Can Fam Physician (1996) 1.42
Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol (1973) 1.42
A short review of the relationship between intestinal permeability and inflammatory joint disease. Clin Exp Rheumatol (1990) 1.42
Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41
Do female primary care physicians practise preventive care differently from their male colleagues? Can Fam Physician (1996) 1.40
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res (Hoboken) (2012) 1.40
Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol (1991) 1.40
Immunogenetics of polymyalgia rheumatica. Clin Exp Rheumatol (1994) 1.40
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med (1990) 1.40
Is diet important in rheumatoid arthritis? Br J Rheumatol (1991) 1.39
Are gallstones less prevalent in rheumatoid arthritis? Clin Rheumatol (1991) 1.39
Evidence based medicine: the median is not the message. J Rheumatol (2001) 1.38
Benefits of hospitalization in rheumatoid arthritis. Q J Med (1974) 1.37
Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol (1987) 1.37
Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J Rheumatol (1999) 1.36
Reliability and learning from the objective structured clinical examination. Med Educ (1990) 1.36
Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis. Curr Med Res Opin (1975) 1.36
The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease. J Rheumatol (1983) 1.35